Acid Base Balance of ICU Patients With Severe Hypoalbuminemia, Before and After an Albumin Infusion, Using Stewart Approach
- Conditions
- Stewart Approach for Acid Base DisordersAdult ICU PatientHypoalbuminemiaHuman Albumin Perfusion
- Interventions
- Other: stewart approach
- Registration Number
- NCT02288494
- Lead Sponsor
- University Hospital, Clermont-Ferrand
- Brief Summary
The primary purpose was to describe the acid base balance of ICU patients with severe hypoalbuminemia using Stewart's approach for acid base disorders, before and after an human albumin perfusion.
- Detailed Description
Prospective study, for ICU patient with severe hypoalbuminemia \< 20g/L, determining biological parameters from Stewart approach for acid base disorders (pH, SIDe, SIDa, SIG, Atot, PaCO2) before, and at 1hour, 2hours and 24 hours after a 200mL 20% human albumin perfusion (the consensus conference ANAES of 1995 recommands to correct hypoalbuminemia below 20g/L).
Clinical parameters (respiratory, haemodynamic, neurologic) were also collected at the same times.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
- serum albuminemia < 20g/L
- adult ICU patient
- Arterial line
- albumin allergy
- pregnancy
- congestive heart failure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description hypoalbuminemia stewart approach The primary purpose was to describe the acid base balance of ICU patients with severe hypoalbuminemia using Stewart's approach for acid base disorders, before and after an human albumin perfusion
- Primary Outcome Measures
Name Time Method changes in pH and independent pH determinants using Stewart approach at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
- Secondary Outcome Measures
Name Time Method changes in hemodynamic parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. changes in respiratory parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion. changes in neurologic parameters at 1 hour, 2 hours and 24 hours after a 200mL of 20% human albumin perfusion.
Trial Locations
- Locations (1)
CHU de Clermont-Ferrand
🇫🇷Clermont-Ferrand, France